Assignee
NOVABIOTICS LTD
GB·9 granted patents·12 pending applications·27 citations·filing 2005–2021
Top patents by PatentIndex Score
21 records- 0190US10905660B2MicroparticlesNOVABIOTICS LTD·Filed 2017·Granted Feb 2, 2021·5 cites·18 claims
- 0288US7847059B2Methods for treatment of a dermatophytic fungal infectionNOVABIOTICS LTD·Filed 2005·Granted Dec 7, 2010·11 cites·22 claims
- 0384US11369568B2Microparticles comprising a sulphur-containing compoundNOVABIOTICS LTD·Filed 2017·Granted Jun 28, 2022·2 cites·16 claims
- 0482US9364491B2Antimicrobial compositions with cysteamineNOVABIOTICS LTD·Filed 2014·Granted Jun 14, 2016·5 cites·9 claims
- 0581US8350003B2Method of treatment of non-dermatophytic fungal infectionsNOVABIOTICS LTD·Filed 2011·Granted Jan 8, 2013·4 cites·18 claims
- 0662US9181303B2Treatment of bacterial infections with cyclic antimicrobial peptidesNOVABIOTICS LTD·Filed 2014·Granted Nov 10, 2015·0 cites·10 claims
- 0761US11020414B2Antimicrobial compositions with cysteamineNOVABIOTICS LTD·Filed 2016·Granted Jun 1, 2021·0 cites·9 claims
- 0860US2019175528A1Inhibition of biofilm organismsNOVABIOTICS LTD·Filed 2019·Application pending·0 cites
- 0956US9518093B2Topical formulation of arginine-rich cyclic antimicrobial peptidesNOVABIOTICS LTD·Filed 2015·Granted Dec 13, 2016·0 cites·8 claims
- 1055US2023338310A1Anti-viral therapyNOVABIOTICS LTD·Filed 2021·Application pending·0 cites
- 1154US2016206575A1Inhibition of Biofilm OrganismsNOVABIOTICS LTD·Filed 2016·Application pending·0 cites
- 1252US2023301895A1Nail formulations and treatment regimesNOVABIOTICS LTD·Filed 2021·Application pending·0 cites
- 1348US12576050B2Dosage regimeNOVABIOTICS LTD·Filed 2019·Granted Mar 17, 2026·0 cites·11 claims
- 1447US2018344671A1Cysteamine as Neutrophil Elastase InhibitorNOVABIOTICS LTD·Filed 2018·Application pending·0 cites
- 1547US2010137222A1Basic Peptides and Their Use as Combined Antibacterial-Antifungine AgentsNOVABIOTICS LTD·Filed 2008·Application pending·0 cites
- 1645US2017348253A1Treatment of Drug-Resistant Microbial InfectionsNOVABIOTICS LTD·Filed 2017·Application pending·0 cites
- 1745US2017348381A1FormulationNOVABIOTICS LTD·Filed 2017·Application pending·0 cites
- 1840US2016102052A1Use of Cysteamine in Treating Infections caused by Yeasts/MouldsNOVABIOTICS LTD·Filed 2015·Application pending·0 cites
- 1940US2016106689A1UseNOVABIOTICS LTD·Filed 2015·Application pending·0 cites
- 2037US2018185305A1An Amino Thiol for Use in the Treatment of an Infection Caused by the Bacterium Mycobacterium SppNOVABIOTICS LTD·Filed 2016·Application pending·0 cites
- 2133US2017107254A1Modified Antimicrobial PeptidesNOVABIOTICS LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →